Introduction Semaglutide, a medication that has taken the healthcare world by storm, is revolutionizing the treatment landscape for individuals with type 2 diabetes and obesity. Initially developed as a treatment for diabetes, Semaglutide belongs to the GLP-1 (glucagon-like peptide-1) receptor agonist class of drugs. By mimicking the natural hormone GLP-1, https://rylanqtxzc.azuria-wiki.com/1093670/semaglutide_a_breakthrough_in_managing_diabetes_weight_loss_and_cardiovascular_health